US Patent Issued to Boehringer Ingelheim Animal Health USA on April 22 for "Modified Marek's disease virus, and vaccines made therefrom" (American, French Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,280,106, issued on April 22, was assigned to Boehringer Ingelheim Animal Health USA Inc. (Duluth, Ga.).

"Modified Marek's disease virus, and vaccines made therefrom" was invented by Joyce Pritchard (Gainesville, Ga.), Teshome Mebatsion (Watkinsville, Ga.) and Michel Bublot (Chaponost, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides an effective vaccine for Marek's disease, which may be prepared using a recombinant Marek's Disease Virus (MDV), strain CVI988, having been transformed with a foreign DNA construct that includes a long terminal repeat sequence of a reticuloendotheliosis virus. This safe viral agent elicits ...